RJA
ACRS icon

Raymond James & Associates’s Aclaris Therapeutics ACRS Stock Holding History

Raymond James & Associates’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-20,995
Closed -$542K – 3284
2017
Q3 		$542K Sell
20,995
-65
-0.3% -$1.68K ﹤0.01% 2427
2017
Q2 		$571K Buy
+21,060
New +$571K ﹤0.01% 2332